New

REZENOPY™ (Naloxone HCI) Nasal Spray

New

REZENOPY™ (Naloxone HCI) Nasal Spray

  • Single-Unit Dose Applicator

Overview

NDC #
Strength
Product/Case Size
NDC #
83245-003-01
Strength
10 mg/0.11 mL
Product/Case Size
(2) pre-filled, single dose intranasal spray devices per carton
83245-003-01
10 mg/0.11 mL
(2) pre-filled, single dose intranasal spray devices per carton

Barcodes

NDC #
GTIN Product Barcode
GTIN Case Barcode
NDC #
83245-003-01
GTIN Product Barcode
GTIN Case Barcode
83245-003-01

Key Info

Compared to: N/A

Free From:

N/A

Rx or OTC:

Rx

Flavor:

N/A

Storage & Handling:

Store REZENOPY nasal spray between 2°C to 25°C (36°F to 77°F). Excursions permitted up to 40°C (104°F). Do not freeze. Do not expose to excessive heat above 40°C (104°F). Keep REZENOPY nasal spray in its box until ready to use. Protect from light.

Indications:

REZENOPY nasal spray is indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression in adult and pediatric patients. REZENOPY nasal spray is intended for immediate administration as emergency therapy in settings where opioids may be present. REZENOPY nasal spray is not a substitute for emergency medical care.